We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CytomX Therapeutics

News List

Astellas, CytomX form T-cell engaging cancer antibodies partnership pharmatimes
March 27, 2020
Astellas has entered into a new partnership with CytomX Therapeutics, in order to develop T-cell engaging bispecific antibodies targeting CD3 and tumour cell surface antigens for the treatment of cancer.
Pfizer Terminates PDC Agreement with CytomX Therapeutics biospace
March 09, 2018
CytomX Therapeutics, Inc，this week Pfizer Inc. notified the Bay Area-based company of its intent to terminate its five-year-old oncology collaboration.
Five Prime names ex-Genentech I-O specialist research SVP fiercebiotech
August 21, 2017
Bryan Irving replaces Luis Borges as SVP of research.